NK
NKTR
Nektar Therapeutics
$69.76
1M -8.2%
3M +17.8%
YTD +60.7%
as of 2026-09-11
✓Watchlist
↑↓ next ticker
· ⌘+↑↓ or scroll to zoom
· ←→ pan · 0 reset
▲ buy
▼ sell · size ≈ trade size
· ─ moving averages ·
click the buttons above to hide them
Model view — historical tendencies for the days ahead, not a forecast
Seasonality
Weak window historically
Next 30 days (to Oct 14): -4.6% median,
32% of the last 31 years finished up.
20-year seasonality chart →
Mean reversion
Deeply oversold — RSI(2) at 9
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought.
Its dip-buy edge in history is +0.12%/day.
Mean-reversion stats →
1-month breakdown —
Market · β 1.18 -0.2% · Seasonal tilt -0.9%
$43M/day volume
83% volatility
+45% 1-year
52-week range · 48% of the way up · -36% from the high
$33.40$109.00
Congressional trades in NKTR
Full tracker →
1 member · 1 buys / 1 sells
· $2K–$30K disclosed · latest filing Oct 2, 2018.
| BUY |
JG Josh Gottheimer
· traded Jun 6, 2018 |
$1K–$15K |
| SELL |
JG Josh Gottheimer
· traded Jun 21, 2018 |
$1K–$15K |
Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.